🔗 Share this article

The prestigious award in Physiology or Medicine was awarded for transformative discoveries that illuminate how the body's defense network attacks harmful infections while protecting the body's own cells.

Three renowned researchers—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—share this honor.

The work uncovered unique "security guards" within the defense system that eliminate rogue immune cells that could attacking the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

The laureates will divide a prize fund valued at 11m Swedish kronor.

Crucial Findings

"Their research has been decisive for comprehending how the immune system operates and the reason we don't all develop serious autoimmune diseases," commented the chair of the award panel.

This trio's studies address a core question: In what way does the defense system defend us from numerous invaders while keeping our healthy cells intact?

Our body's protection system uses immune cells that search for indicators of infection, including viruses and germs it has not met before.

These defenders utilize sensors—known as receptors—that are generated randomly in a vast number of variations.

That gives the defense network the capacity to fight a broad range of invaders, but the randomness of the mechanism unavoidably creates white blood cells that may attack the host.

Security Guards of the Body

Researchers earlier knew that some of these problematic white blood cells were destroyed in the immune organ—where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the body to neutralize other immune cells that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "These discoveries have laid the foundation for a novel area of investigation and spurred the development of new therapies, for example for tumors and immune disorders."

In malignancies, T-regs prevent the body from fighting the tumor, so studies are focused on lowering their quantity.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the organism is not under attack. A similar method could also be effective in minimizing the risks of organ transplant rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.

The researcher showed that introducing immune cells from healthy animals could stop the illness—suggesting there was a mechanism for preventing defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in mice and people that resulted in the identification of a gene vital for how regulatory T-cells function.

"Their groundbreaking research has revealed how the immune system is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"This research is a striking example of how fundamental biological research can have far-reaching implications for human health."